Semaglutide (5 mg) is a long-acting synthetic peptide commonly studied in metabolic and endocrine research
The compounded GLP-1 market changes rapidly as regulatory pressures and legal challenges reshape the industry
specializing in weight management, GLP-1 medication nutrition therapy, bariatric surgery, digestive health, and sustainable behavior change Leah Jones, MD Board-certified in Internal Medicine and Obesity Medicine Katherine Austin, MD, MPH, FAAP, FRCP(C) Board-certified in Pediatrics and Adolescent Medicine Heather Cecchini, MSN, APRN, ANP-C Board-certified Adult-Primary Care Nurse Practitioner Clete Barrick, MD Board-certified in Internal Medicine and Obesity Medicine Caitlin Camill, RDN, CDCES Certified Diabetes Care and Education Specialist
Safety when exploring alternatives Each treatment has different safety points and dosing plans
It's important to consider other potential causes, including concurrent medications (such as metformin), vitamin deficiencies, or oral/dental conditions